Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will
Inpharmus is steadily increasing its presence in global healthcare by using its strong knowledge of rare diseases and cancer treatments, along with a team of
NeoGenomics, Inc. , a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic Therapeutics, Ltd a targeted oncology therapeutics company dedicated to resolving
Real-world data study aims to improve treatment options for chronic lymphocytic leukemia and small lymphocytic lymphoma patients nference, a company dedicated to transforming healthcare by
The Arkansas-based not-for-profit now uses DeepScribe’s oncology-specific AI to document and deliver insights for patients DeepScribe, the industry-leading ambient AI for oncology care, has been selected by CARTI,
MSInsight, an innovative start-up specializing in precision medicine in oncology, announces the successful completion of its €1.6 million seed funding round. This fundraising was carried
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease,
